A Study of Live Tumor Fragments of Surgical Resections
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: No intervention.
- Who it may be relevant to
- Registry conditions: Cancer, Tumor. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Predicting Response to Therapy From Analysis of Live Tumor Fragments of Surgical Resections
Overview
The purpose of this study is to obtain unused resected tumor tissue sample and associated clinical data from patients enrolled in this study to research ex vivo treatment response and integrity of tumor microenvironment using omics analysis and imaging while maintaining cell stability in a live environment.
Interventions
- Other No intervention
Lab-based correlative study; no intervention
Primary outcome measures
- Tissue response to treatment [Time frame: Up to 72 hours]
Eligibility criteria
Inclusion criteria
- Ability to understand and sign informed consent
- Planning to undergo a surgical procedure to remove cancer
Exclusion criteria
- Does not meet Inclusion criteria
- No tissue for research available at time of surgery
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- Mayo Clinic in Florida — Jacksonville
Identifiers
NCT: NCT07000864 · MC250101 · 25-002240